Hermetica Superfood Encyclopedia
The Short Answer
Grias neuberthii pulp contains exceptionally high concentrations of quercetin (944.2 mg/100 g DW), caffeic acid (179.9 mg/100 g DW), p-hydroxybenzoic acid (398.3 mg/100 g DW), and total carotenoids (46.1 mg/100 g DW), which collectively drive its antioxidant and antimicrobial activities. In vitro, fruit extract-coated silver nanoparticles induced dose-dependent cytotoxicity in MCF-7 breast cancer cells at concentrations above 50 µM after 48 hours, linked to cell cycle arrest and downregulation of the p53 transcription factor.
CategoryFruit
GroupAmazonian
Evidence LevelPreliminary
Primary KeywordGrias neuberthii benefits
Apai — botanical close-up
Health Benefits
**Antioxidant Activity**
Freeze-dried pulp demonstrates an ABTS radical scavenging capacity of 6.7 mmol ET/100 g DW, attributable to the combined action of quercetin, caffeic acid, chlorogenic acid, and carotenoids including lutein and zeinoxanthin.
**Antimicrobial Properties**
Crude fruit extracts exhibit antimicrobial activity against Staphylococcus aureus with a minimum inhibitory concentration (MIC) of 10.6 mg/mL and against other tested pathogens at MICs ranging up to 21.6 mg/mL, suggesting broad-spectrum activity driven by its phenolic constituents.
**Potential Anticancer Activity**
Extract-coated silver nanoparticles (AgNPs) selectively induced cytotoxicity in MCF-7 human breast cancer cells in a dose-dependent manner above 50 µM at 48 hours, with no significant effect observed in HeLa cervical cancer cells, implying cell-type-specific mechanisms.
**Rich Carotenoid Source**: With total carotenoids reaching 46
1 mg/100 g DW—reported as the highest among a panel of studied Amazonian fruits—including lutein (1.4 mg/100 g DW) and zeinoxanthin (1.3 mg/100 g DW), the fruit may support eye health and reduce oxidative stress in ocular tissues.
**Phenolic-Driven Anti-inflammatory Potential**
High concentrations of quercetin, syringic acid (81.6 mg/100 g DW), and p-hydroxybenzoic acid (398.3 mg/100 g DW) are known to inhibit NF-κB signaling and cyclooxygenase enzymes in preclinical models, suggesting an anti-inflammatory mechanism that has not yet been directly studied in this fruit.
**Vitamin C Content**: The pulp provides 25
4 mg vitamin C per 100 g DW, contributing to immune support and collagen biosynthesis, and acting synergistically with carotenoids to regenerate oxidized lipophilic antioxidants.
**Cytotoxic Activity Against Colon Cancer Cells**
Compounds isolated from Grias neuberthii seed and fruit extracts demonstrated cytotoxic properties against human colon cancer cell lines at concentrations of 5–50 µg/mL in preliminary in vitro assays, though the specific molecular targets remain uncharacterized.
Origin & History
Natural habitat
Grias neuberthii is a large-fruited tree native to the Amazon basin of South America, particularly found in Ecuador and Peru, belonging to the Lecythidaceae family alongside the Brazil nut. It thrives in lowland tropical rainforest conditions with high humidity, abundant rainfall, and rich alluvial soils near riverbanks. The tree is harvested by indigenous Amazonian communities, with its pulp, seeds, and flowers all considered useful, and it is commonly referred to as 'apai' or 'piton' in regional vernacular.
“Grias neuberthii is endemic to the Amazon rainforest and has long been part of the food and traditional medicine repertoire of indigenous communities in Ecuador and Peru, where the fruit is known locally as 'apai' or 'piton.' Traditional knowledge attributes antitumour and general health-protective properties to the seeds, flowers, and pulp, though the precise preparation methods, dosing frameworks, and specific ailments treated have not been formally documented in the ethnobotanical literature reviewed. The fruit belongs to the Lecythidaceae family, a plant group with multiple members used across Amazonian and tropical cultures for nutritional and medicinal purposes, lending broader cultural context to its traditional value. Formal ethnopharmacological studies specifically documenting Grias neuberthii's historical use in codified traditional medicine systems remain sparse, representing a significant gap in the existing literature.”Traditional Medicine
Scientific Research
The current evidence base for Grias neuberthii consists entirely of in vitro and analytical chemistry studies, with no published clinical trials or animal model investigations identified in the literature. Compositional analyses of freeze-dried pulp have quantified specific phenolics, carotenoids, and vitamin C with precision (e.g., quercetin 944.2 ± 19.2 mg/100 g DW), lending credibility to phytochemical characterizations, but these studies provide no pharmacokinetic or efficacy data in humans. Antimicrobial assays using MIC methodology against S. aureus and other pathogens and cytotoxicity studies employing MCF-7 and HeLa cell lines represent the extent of mechanistic research, and no sample sizes reflecting in vivo populations, effect sizes in biological systems, or dose-response relationships in living organisms have been reported. Overall, the evidence is early-stage and exploratory; while the phytochemical profile is scientifically compelling, no conclusions about therapeutic efficacy or safety in humans can be drawn.
Preparation & Dosage
Traditional preparation
**Fresh Pulp**
Consumed traditionally in Amazonian communities as a whole fruit; no standardized serving size for health purposes has been established.
**Freeze-Dried Pulp Powder**
Used in research settings for bioactive quantification; no commercial supplement dose has been validated in clinical studies.
**Crude Hydroalcoholic Extract**
6 mg/mL for antimicrobial endpoints, but these concentrations are not translatable to oral supplement doses without bioavailability data
Prepared for antimicrobial and antioxidant assays in laboratory contexts; effective concentrations in vitro range from 10.6–21..
**Silver Nanoparticle (AgNP) Formulation**
Fruit extract-coated AgNPs were used in cytotoxicity research at 50–160 µM; this is an experimental delivery format not available as a consumer supplement.
**Traditional Preparation**
Seeds, flowers, and pulp are reportedly used by indigenous Amazonian peoples in food and folk medicine contexts; no documented historical recipe or preparation protocol has been formally recorded in the reviewed literature.
**Standardization**
No commercial extract standardization percentages for any marker compound (e.g., quercetin content) have been established or published.
Nutritional Profile
Grias neuberthii freeze-dried pulp contains vitamin C at 25.4 mg/100 g DW, contributing to daily ascorbic acid needs, though bioavailability from dried matrices may differ from fresh fruit. Total carotenoids reach 46.1 mg/100 g DW, with identified fractions including the xanthophylls lutein (1.4 ± 0.1 mg/100 g DW) and zeinoxanthin (1.3 ± 0.1 mg/100 g DW); carotenoid bioavailability is generally enhanced by co-ingestion with dietary fats. The phenolic fraction is exceptionally rich, dominated by quercetin (944.2 ± 19.2 mg/100 g DW), p-hydroxybenzoic acid (398.3 ± 32.5 mg/100 g DW), caffeic acid (179.9 ± 4.8 mg/100 g DW), syringic acid (81.6 ± 1.1 mg/100 g DW), chlorogenic acid (48.6 ± 2.2 mg/100 g DW), naringenin (28.2 ± 1.6 mg/100 g DW), and gallic acid (12.4 ± 0.2 mg/100 g DW). Organic acid content is notable, with total organic acids in compositionally similar Amazonian fruits ranging from 1063.6 to 3887.7 mg/100 g DW, though precise values for Grias neuberthii alone have not been independently reported; macro- and micronutrient profiles beyond these compounds are not yet characterized in the published literature.
How It Works
Mechanism of Action
The antioxidant activity of Grias neuberthii is primarily mediated by electron-donating polyphenols—notably quercetin and caffeic acid—which donate hydrogen atoms to neutralize reactive oxygen species (ROS) and chelate redox-active metal ions that catalyze lipid peroxidation. In anticancer studies, fruit extract-functionalized silver nanoparticles (AgNPs) induced cell cycle arrest in MCF-7 breast cancer cells and downregulated p53 transcription factor expression in a dose-dependent manner above 50 µM, without altering glutathione S-transferase (GST) expression or reducing viability in HeLa cells, implying selective cytotoxic signaling rather than generalized oxidative toxicity. The antimicrobial mechanism is attributed to phenolic compounds, particularly gallic acid and chlorogenic acid, which disrupt bacterial membrane integrity, inhibit cell wall biosynthesis enzymes, and interfere with metabolic enzymes in gram-positive organisms such as S. aureus at MICs of 10.6 mg/mL. Carotenoids including lutein and zeinoxanthin function as singlet oxygen quenchers within lipid membranes, contributing to the overall reductive capacity measured at 6.7 mmol ET/100 g DW by ABTS assay.
Clinical Evidence
No clinical trials involving human subjects have been conducted on Grias neuberthii or its isolated constituents as of the current evidence review. All available data derive from in vitro cell-based assays (MCF-7, HeLa, and colon cancer cell lines) and antimicrobial broth microdilution studies, none of which constitute clinical evidence. Effect sizes reported—such as >50% cytotoxicity at >50 µM AgNPs after 48 hours and MIC of 10.6 mg/mL against S. aureus—are relevant as hypothesis-generating findings but cannot be extrapolated to human dosing or therapeutic outcomes. Confidence in any clinical application is very low, and the ingredient remains at an early preclinical stage of investigation.
Safety & Interactions
No formal human safety studies, toxicology assessments, or pharmacovigilance data exist for Grias neuberthii in any preparation form, making it impossible to establish a maximum safe dose or confirm the absence of adverse effects in humans. In vitro data with AgNP-extract formulations showed no significant reduction in HeLa cell viability at concentrations up to 160 µM, and antimicrobial MICs of 10.6–21.6 mg/mL suggest relatively low inherent toxicity of crude extracts at effective antimicrobial concentrations; however, these findings cannot be reliably extrapolated to in vivo safety. No drug interactions, contraindications, or guidance for use during pregnancy or lactation have been studied or reported; given the high quercetin content (944.2 mg/100 g DW), theoretical interactions with CYP3A4-metabolized drugs and P-glycoprotein substrates cannot be excluded based on known quercetin pharmacology. Individuals with allergies to the Lecythidaceae family or those taking anticoagulant, antiplatelet, or immunosuppressive medications should exercise caution and consult a healthcare provider before consuming concentrated preparations.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
PitonApai (Grias neuberthii)Grias neuberthii MacBrideApaiMonkey pot relativeLecythidaceae Amazonian fruit
Frequently Asked Questions
What are the main bioactive compounds in Grias neuberthii?
Grias neuberthii freeze-dried pulp contains exceptionally high levels of quercetin (944.2 mg/100 g DW), p-hydroxybenzoic acid (398.3 mg/100 g DW), caffeic acid (179.9 mg/100 g DW), and total carotenoids (46.1 mg/100 g DW) including lutein and zeinoxanthin. Vitamin C at 25.4 mg/100 g DW and additional phenolics such as chlorogenic acid and gallic acid round out a diverse phytochemical profile with demonstrated in vitro antioxidant and antimicrobial activities.
Does Grias neuberthii have anticancer properties?
In vitro studies show that Grias neuberthii fruit extract-coated silver nanoparticles (AgNPs) induce dose-dependent cytotoxicity in MCF-7 human breast cancer cells at concentrations above 50 µM after 48 hours, associated with cell cycle arrest and downregulation of p53 transcription factor expression. Additionally, fruit and seed extracts have shown cytotoxic activity against human colon cancer cell lines at 5–50 µg/mL, but no animal studies or human clinical trials have been conducted, so anticancer claims in humans are not supported by current evidence.
Is Grias neuberthii safe to consume?
No human safety studies, formal toxicology assessments, or documented adverse events exist for Grias neuberthii in any form, so a definitive safety profile cannot be established. In vitro experiments found no notable cytotoxicity to HeLa cells at AgNP concentrations up to 160 µM, and crude extract MICs suggest low inherent toxicity at effective antimicrobial concentrations, but these findings do not confirm human safety, and individuals taking medications metabolized by CYP3A4 enzymes should use caution given the high quercetin content.
What is the recommended dose of Grias neuberthii supplement?
No established supplemental dose for Grias neuberthii exists in any published clinical guideline, pharmacopeial monograph, or human study, as all research has been conducted in cell culture or antimicrobial assay settings. The fruit is consumed traditionally as food in Amazonian communities, but no standardized extract product with validated dosing has been commercialized or evaluated in clinical trials, meaning any dose used in a supplement context would be entirely empirical.
How does Grias neuberthii compare to other Amazonian antioxidant fruits?
Comparative phytochemical analyses indicate that Grias neuberthii has the highest total carotenoid content (46.1 mg/100 g DW) among a panel of studied Amazonian fruits, and its quercetin concentration of 944.2 mg/100 g DW is remarkably elevated relative to commonly studied fruits. Its ABTS antioxidant capacity of 6.7 mmol ET/100 g DW and broad-spectrum antimicrobial activity (MIC 10.6 mg/mL against S. aureus) position it as a noteworthy candidate for further research, though widely studied Amazonian fruits like açaí have far more clinical and human bioavailability data supporting their use.
What is the antimicrobial activity of Grias neuberthii and against which pathogens?
Grias neuberthii crude fruit extracts demonstrate antimicrobial activity primarily against Staphylococcus aureus, with measurable minimum inhibitory concentrations that suggest potential applications in combating bacterial infections. This antimicrobial property complements the fruit's antioxidant profile and may contribute to its traditional use in Amazonian medicine. However, clinical efficacy in humans requires further research beyond these in vitro findings.
Which bioactive compounds in Grias neuberthii are responsible for its antioxidant effects?
Grias neuberthii's antioxidant capacity is attributed to a synergistic blend of polyphenols (quercetin, caffeic acid, and chlorogenic acid) and carotenoids including lutein and zeinoxanthin. The freeze-dried pulp exhibits an ABTS radical scavenging capacity of 6.7 mmol ET/100 g dry weight, indicating significant free radical neutralization potential. This combination of compounds works together to provide broader antioxidant coverage than any single component alone.
What form of Grias neuberthii provides the best antioxidant stability?
Freeze-dried pulp of Grias neuberthii demonstrates reliable antioxidant activity measurements and is considered a stable form for preserving the fruit's bioactive compounds compared to fresh preparations. The freeze-drying process removes water while maintaining the integrity of heat-sensitive polyphenols and carotenoids that would degrade during conventional drying or processing. This form is particularly advantageous for supplement formulation and maintaining long-term potency of the ingredient.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w grias-neuberthii-grias-neuberthii-macbride curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
